Show simple item record

dc.creatorKumar Samrat, Subodh
dc.creatorTharappel, Anil M.
dc.creatorLi, Zhong
dc.creatorLi, Hongmin
dc.date.accessioned2020-08-26T16:46:16Z
dc.date.available2020-08-26T16:46:16Z
dc.date.created2020
dc.identifier.issn0168-1702spa
dc.identifier.otherhttps://doi.org/10.1016/j.virusres.2020.198141spa
dc.identifier.urihttp://hdl.handle.net/20.500.12010/12320
dc.description.abstractThe recent outbreak of the betacoronavirus SARS-CoV-2 has become a significant concern to public health care worldwide. As of August 19, 2020, more than 22,140,472 people are infected, and over 781,135 people have died due to this deadly virus. In the USA alone, over 5,482,602 people are currently infected, and more than 171,823 people have died. SARS-CoV-2 has shown a higher infectivity rate and a more extended incubation period as compared to previous coronaviruses. SARS-CoV-2 binds much more strongly than SARS-CoV to the same host receptor, angiotensin-converting enzyme 2 (ACE2). Previously, several methods to develop a vaccine against SARS-CoV or MERS-CoV have been tried with limited success. Since SARSCoV-2 uses the spike (S) protein for entry to the host cell, it is one of the most preferred targets for making vaccines or therapeutics against SARS-CoV-2. In this review, we have summarised the characteristics of the S protein, as well as the different approaches being used for the development of vaccines and/or therapeutics based on the S protein.spa
dc.format.extent70 páginasspa
dc.format.mimetypeimage/jepgspa
dc.language.isoengspa
dc.publisherVirus Researchspa
dc.sourcereponame:Expeditio Repositorio Institucional UJTLspa
dc.sourceinstname:Universidad de Bogotá Jorge Tadeo Lozanospa
dc.subjectSARS-CoV-2spa
dc.subjectPublic healthspa
dc.subjectMERS-CoVspa
dc.subjectVaccinespa
dc.subjectTherapeutic developmentspa
dc.titleProspect of SARS-CoV-2 spike protein: Potential role in vaccine and therapeutic developmentspa
dc.type.localArtículospa
dc.subject.lembSíndrome respiratorio agudo gravespa
dc.subject.lembCOVID-19spa
dc.subject.lembSARS-CoV-2spa
dc.subject.lembCoronavirusspa
dc.rights.accessrightsinfo:eu-repo/semantics/embargoedAccessspa
dc.type.hasversioninfo:eu-repo/semantics/acceptedVersionspa
dc.rights.localAcceso restringidospa
dc.identifier.doihttps://doi.org/10.1016/j.virusres.2020.198141spa
dc.type.coarhttp://purl.org/coar/resource_type/c_2df8fbb1spa


Files in this item

Thumbnail
Thumbnail

This item appears in the following Collection(s)

Show simple item record